|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 158 TWD | -.--% |
|
-2.77% | +3.95% |
Syngen Biotech Co.,Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was TWD 467.56 million compared to TWD 444.1 million a year ago. Net income was TWD 59.75 million compared to TWD 72.92 million a year ago.
Basic earnings per share from continuing operations was TWD 2.2 compared to TWD 2.69 a year ago. Diluted earnings per share from continuing operations was TWD 2.2 compared to TWD 2.69 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +3.95% | 132M | |
| +55.32% | 815B | |
| +44.05% | 641B | |
| -6.75% | 352B | |
| +13.56% | 314B | |
| +10.68% | 303B | |
| +16.57% | 242B | |
| +2.04% | 224B | |
| +13.31% | 218B | |
| +8.48% | 168B |
SYNGEN BIOTECH CO.,LTD. 
